Other stimulant dependence with other stimulant-induced disorder
ICD-10 F15.288 is a billable code used to indicate a diagnosis of other stimulant dependence with other stimulant-induced disorder.
F15.288 refers to a condition characterized by dependence on stimulants that are not classified as amphetamines or cocaine, accompanied by other stimulant-induced disorders. This may include substances such as methamphetamine, ecstasy, or other synthetic stimulants. Patients may exhibit symptoms of withdrawal, intoxication, or other mental health disorders as a result of their stimulant use. The clinical presentation can vary widely, including anxiety, agitation, psychosis, or cardiovascular complications. Treatment typically involves a combination of behavioral therapies, counseling, and in some cases, pharmacotherapy to manage withdrawal symptoms and co-occurring mental health issues. Accurate diagnosis and coding are crucial for effective treatment planning and insurance reimbursement.
Detailed history of substance use, treatment history, and mental health evaluation.
Patients presenting with withdrawal symptoms, cravings, or complications from stimulant use.
Consideration of comorbid psychiatric conditions and the need for a multidisciplinary treatment approach.
Comprehensive psychiatric evaluation, including mental status examination and risk assessment.
Patients with stimulant-induced psychosis or mood disorders requiring psychiatric intervention.
Documentation of the impact of stimulant use on mental health and any necessary psychiatric treatments.
Used when assessing a patient for stimulant dependence and related disorders.
Document the assessment findings and treatment recommendations.
Addiction specialists should ensure comprehensive evaluations are performed.
Common symptoms include anxiety, agitation, psychosis, cardiovascular issues, and withdrawal symptoms such as fatigue and depression.
